These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 12055705)

  • 1. Benefits of sustained moderate weight loss in obesity.
    Pasanisi F; Contaldo F; de Simone G; Mancini M
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
    Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nutrition and health--ideal body weight for the obese unrealistic; health benefit by moderate sustained weight loss].
    Mathus-Vliegen EM
    Ned Tijdschr Geneeskd; 2003 Jun; 147(24):1168-72. PubMed ID: 12845836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome success in obesity.
    Klein S
    Obes Res; 2001 Nov; 9 Suppl 4():354S-358S. PubMed ID: 11707565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
    Mertens IL; Van Gaal LF
    Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the benefits of moderate weight loss?
    de Leiva A
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():10-3. PubMed ID: 9792475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity.
    Stern JS; Hirsch J; Blair SN; Foreyt JP; Frank A; Kumanyika SK; Madans JH; Marlatt GA; St Jeor ST; Stunkard AJ
    Obes Res; 1995 Nov; 3(6):591-604. PubMed ID: 8653537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Leiter LA; Abbott D; Campbell NR; Mendelson R; Ogilvie RI; Chockalingam A
    CMAJ; 1999 May; 160(9 Suppl):S7-12. PubMed ID: 10333848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM; Bastiaans K; Keogh JB
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a classroom-based weight-control intervention on cardiovascular disease in elementary-school obese children.
    Huang SH; Weng KP; Hsieh KS; Ou SF; Lin CC; Chien KJ; Liu PY; Ho TY
    Acta Paediatr Taiwan; 2007; 48(4):201-6. PubMed ID: 18265541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.